Archive - April 2008

• Australian GPs lead the world in cardiovascular prevention (30/04/2008)
• A focus on adherence may improve cardiovascular outcomes (29/04/2008)
• Scant evidence to support specialised palliative care (29/04/2008)
• Drug-eluting stents beneficial for both type I and type II diabetes patients (29/04/2008)
• Unproven genetic test warning (29/04/2008)
• Men have more to gain from prevention strategies: INTERHEART (27/04/2008)
• Anti-angina drug linked to ulceration (27/04/2008)
• “Lifelong” treatment needed for obesity (27/04/2008)
• RCT results confirm statin-induced reductions in blood pressure (23/04/2008)
• Migraine frequency linked with CVD risk (22/04/2008)
• Smoking tops costs list (22/04/2008)
• DASH style diet lowers risk of CHD and stroke in women (22/04/2008)
• Baseline CV risk key to COX-2 prescribing (20/04/2008)
• Rights to free speech do not justify relaxation of restrictions on drug promotion (20/04/2008)
• Diabetes specialist physicians: do they still have a role? (18/04/2008)
• Rosuvastatin produces regression of coronary atherosclerosis – ASTEROID study (18/04/2008)
• Low blood pressure and lipid targets achievable in diabetes patients (14/04/2008)
• Power of the placebo: study reveals three additive components (14/04/2008)
• Kidney screen at age 50 detects CHD (13/04/2008)
• Empathy: valuable in doctors, but don’t forget competence (13/04/2008)
• Most heparin supplies given the all clear (11/04/2008)
• Patients to be rated on script compliance (11/04/2008)
• Management of carotid stenosis (11/04/2008)
• Bystanders can use hands-only CPR, says AHA (11/04/2008)
• Tirofiban not inferior to abciximab: MULTISTRATEGY (07/04/2008)
Displaying results 1-25 (of 36)
 |<  < 1 - 2  >  >| 

Back to archive ...